Warren: Biden must ‘break patent barriers’ to drive down drug costs
26-04-2022
Dems pressure Biden to share Moderna vaccine tech
14-10-2021
Lawmakers urge USPTO to curb IPR denials under Fintiv
21-09-2021
David Garcia / Shutterstock.com
US Senator Elizabeth Warren has urged the Department of Health and Human Services (HHS) to seize control of patents covering Pfizer’s prostate cancer drug Xtandi (enzalutamide).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Elizabeth Warren, Pfizer, Xtandi, Bayh-Dole Act, march-in, government, patents, medicines, cancer, Xavier Becerra
